全球注册 | 韩国

你在韩国的许可持有人

作为在韩国的全球注册专家,我们确保您的产品符合韩国食品药品安全部 (MFDS) 的所有监管要求,助您成功进入韩国市场。

韩国许可持有人(KLH)

在韩国,必须具备一个韩国本地的注册地址或指定一位韩国许可持有人,以作为与韩国食品药品安全部 (MFDS) 的联络人。

根据不同的产品的分类,注册期限为2到16个月。对于I类产品,可以获得基本的KGMP证书。如果您的设备属于I类(特殊控制类)、II类、III类或IV类,则必须向MFDS提交详细的技术档案,并提供样品设备以进行测试。

CMC 可以通过在韩国食品药品安全部 (KFDA) 注册您的产品,帮助您进入韩国市场。

2025年9月12日新添加
2025年9月12日新添加-联系我们表单提交

请填写联系表格,我们的顾问会尽快与您联系。

在世界各地找到我们

    后台栏目
    摘要
    2025年9月12日新添加-2

    Frequently asked questions about TGA Registration

    2025年9月12日新添加-3

    Manufacturers based outside the EU are legally obliged to appoint an Authorized Representative (EC REP) so that their products can legally circulate within the European Union market.

    Regardless of whether a medical device requires the intervention of a Notified Body (in the case of Class I sterile/measuring/reusable, IIa, IIb and III) to obtain CE Marking, or whether the manufacturer can self-certify (Class I simple), those operating outside the EU must appoint an Authorized Representative so that their products can be placed on the European market.

    The Authorized Representative plays a crucial role in ensuring device compliance, acting as the point of contact within the Union. The Authorized Representative’s minimum responsibilities include:

    ● Verifying that the technical documentation and other essential documents have been prepared and that the manufacturer has fulfilled its registration obligations.

    ● Providing the competent authority with all information and documentation necessary to demonstrate the conformity of a device.

    ● Transmit to the manufacturer any request from the competent authority to obtain samples of the device.

    ● Collaborate with the competent authorities in any preventive or corrective actions aimed at eliminating or mitigating risks that devices may present.

    ● Immediately inform the manufacturer of complaints and reports from healthcare professionals, patients and users about possible incidents related to a device for which they have been designated.

    The European Authorized Representative (EC-REP or EAR) shares responsibility in case of defective products and is obliged to terminate the contract with the manufacturer if the manufacturer acts inconsistently with its obligations. Therefore, the EAR is responsible for defective products when the manufacturer has not fulfilled its obligations under the Medical Device Regulation (MDR).

    Yes. Any manufacturer that is established outside the European Union is required to appoint an Authorized Representative (EC REP) based in the EU.
    This requirement is essential for placing medical devices or IVDs on the market in accordance with Regulation (EU) 2017/745 (MDR) and Regulation (EU) 2017/746 (IVDR).
    Without a designated EC REP, it is not legally possible to access the European market.

    Not always. In some cases, an importer or distributor can be designated as the Authorized Representative, but this must be done formally and in full compliance with legal requirements.
    However, this practice may lead to conflicts of interest.
    Therefore, it is recommended to choose an independent EC REP with expertise in regulatory compliance.

    Yes. The name and address of the Authorized Representative must appear on the product labeling, the outer packaging, or the Instructions for Use (IFU).
    In addition, the official EC REP symbol, as specified in ISO 15223-1, must be included.
    This information must be clear, visible, and legible to meet the requirements of the MDR and IVDR.

    Yes. It is possible to change your Authorized Representative at any time.
    The current and new EC REPs must coordinate the transfer of responsibilities to maintain regulatory compliance.
    The manufacturer must also update the labeling, technical documentation, and EUDAMED records, if applicable.

    For medical devices and in-vitro diagnostic devices, EU Regulations (MDR and IVDR) mandate that non-EU manufacturers appoint an authorized representative based in the EU. This representative is crucial for ensuring compliance and acts as a primary contact point within the EU.

    Since 2014, CMC Medical Devices has been dedicated to providing representation and consultancy services to manufacturers seeking entry into the EU market. Our headquarters, located in Spain, places us strategically to work closely with EU institutions. We are actively involved in European Commission Working Groups and Horizon Europe, the EU’s research and innovation program, shaping the compliance landscape over the years.
    CMC Medical Devices is also a member of the European Association of Authorised Representatives (EAAR) and a founding member of the European Responsible Person Association (ERPA), both organizations committed to maintaining high standards of service and professionalism.
    We highly recommend choosing a professional representative for your company within the EU. CMC Medical Devices offers:

    ● A team of experts to guide you through the compliance process
    ● Confidential handling of all shared information
    ● No conflict of interest, as we do not engage in manufacturing or selling products
    ● Up-to-date information on regulatory changes

    Since our establishment, CMC Medical Devices has grown significantly and is a reference company in Europe for regulatory compliance. Our experts are well-equipped to help you navigate the EU, UK, and Swiss markets.

    2025年9月12日新添加-4

    Why appoint CMC Medical Devices as your TGA Sponsor?